Javascript must be enabled to continue!
Unveiling Impurities: A Comprehensive RP-HPLC Method for Accurate Atorvastatin Impurity Analysis in Pharmaceuticals Using an Accuracy Profile Approach
View through CrossRef
Abstract
Background
Accurate determination of active pharmaceutical ingredients and impurities is essential for ensuring the safety and effectiveness of medications. This study focuses on the validation of a high-performance liquid chromatography (HPLC) method for quantifying atorvastatin and its impurities, addressing a critical aspect of pharmaceutical analysis.
Objective
The primary objective is to conduct a comprehensive validation study for the HPLC method, covering specificity assessment, response function establishment, and a detailed analysis of precision, trueness, and tolerance intervals. The emphasis is on demonstrating the method’s precision, accuracy, and stability-indicating capabilities across various concentrations and compounds.
Methods
The HPLC method is validated through rigorous assessments, including specificity, response function establishment, and analyses of precision, trueness, and tolerance intervals. Induced degradation experiments are conducted to explore atorvastatin’s behavior under extreme conditions. Insights into the compound’s synthesis and degradation pathways are provided through a proposed mechanism for intramolecular esterification.
Results
The results affirm the precision, accuracy, and stability-indicating capabilities of the validated HPLC method. The method effectively differentiates between atorvastatin and its impurities, showcasing its suitability for pharmaceutical quality control.
Conclusions
The validated HPLC method emerges as a robust and reliable tool for atorvastatin analysis, contributing significantly to pharmaceutical research and quality control. Its application ensures the safety and efficacy of medications, reinforcing its role in pharmaceutical analysis.
Highlights
This study not only validates a crucial HPLC method for atorvastatin analysis but also provides insights into the compound’s behavior under extreme conditions and its synthesis and degradation pathways. The validated method serves as a cornerstone in pharmaceutical research and quality control, ensuring medication safety and efficacy.
Title: Unveiling Impurities: A Comprehensive RP-HPLC Method for Accurate Atorvastatin Impurity Analysis in Pharmaceuticals Using an Accuracy Profile Approach
Description:
Abstract
Background
Accurate determination of active pharmaceutical ingredients and impurities is essential for ensuring the safety and effectiveness of medications.
This study focuses on the validation of a high-performance liquid chromatography (HPLC) method for quantifying atorvastatin and its impurities, addressing a critical aspect of pharmaceutical analysis.
Objective
The primary objective is to conduct a comprehensive validation study for the HPLC method, covering specificity assessment, response function establishment, and a detailed analysis of precision, trueness, and tolerance intervals.
The emphasis is on demonstrating the method’s precision, accuracy, and stability-indicating capabilities across various concentrations and compounds.
Methods
The HPLC method is validated through rigorous assessments, including specificity, response function establishment, and analyses of precision, trueness, and tolerance intervals.
Induced degradation experiments are conducted to explore atorvastatin’s behavior under extreme conditions.
Insights into the compound’s synthesis and degradation pathways are provided through a proposed mechanism for intramolecular esterification.
Results
The results affirm the precision, accuracy, and stability-indicating capabilities of the validated HPLC method.
The method effectively differentiates between atorvastatin and its impurities, showcasing its suitability for pharmaceutical quality control.
Conclusions
The validated HPLC method emerges as a robust and reliable tool for atorvastatin analysis, contributing significantly to pharmaceutical research and quality control.
Its application ensures the safety and efficacy of medications, reinforcing its role in pharmaceutical analysis.
Highlights
This study not only validates a crucial HPLC method for atorvastatin analysis but also provides insights into the compound’s behavior under extreme conditions and its synthesis and degradation pathways.
The validated method serves as a cornerstone in pharmaceutical research and quality control, ensuring medication safety and efficacy.
Related Results
A digitized impurity database analysis method for determining the impurity profiles of gatifloxacin in bulk materials and injections
A digitized impurity database analysis method for determining the impurity profiles of gatifloxacin in bulk materials and injections
HPLC has become the most important analytical technique for impurity profiling in order to assure the quality of pharmaceutical products. Although HPLC is considered as a well-esta...
Identify and Assess Drug Interactions with Atorvastatin in Inpatient Care
Identify and Assess Drug Interactions with Atorvastatin in Inpatient Care
Background: Atorvastatin is a recent HMG-COA reductase inhibitor used to treat primary hypercholesterolemia, homozygous familial hypercholesterolemia, and mixed dyslipidemias. It i...
Regulatory aspects of Impurity profiling
Regulatory aspects of Impurity profiling
Quality, safety and efficacy of pharmaceuticals play an important role in drug therapy. The safety attribute of drug is established by its pharmacological or toxicological profile ...
Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay
Identification and in vitro genotoxicity assessment of forced degradation products of glimepiride and glyburide using HEK cell‐based COMET assay
AbstractThis study focuses on characterizing the forced degradation products of antidiabetic drugs glimepiride (GMD) and glyburide (GBD), with previously unexplored genotoxicity. D...
Profil Klinik dan Farmakoterapi Anti-Dislipidemia Diabetes di Rumah Sakit Gunawan Mangunkusumo Ambarawa
Profil Klinik dan Farmakoterapi Anti-Dislipidemia Diabetes di Rumah Sakit Gunawan Mangunkusumo Ambarawa
Dyslipidemia is characterized by increased plasma TG, low HDL-c, and high LDL-c, which is commonly found in patients with diabetes mellitus (DM) and is one of the main causes of is...
Simultaneous Quantification RP-HPLC Method Development and Validation for Atorvastatin and Tadalafil in Bulk Form
Simultaneous Quantification RP-HPLC Method Development and Validation for Atorvastatin and Tadalafil in Bulk Form
Background: Tadalafil and Atorvastatin together have been shown to significantly enhance hemodynamics and sexual performance in middle-aged and older patients with hyperlipidemia. ...
Simultaneous Quantification RP-HPLC Method Development and Validation for Atorvastatin and Tadalafil in Bulk Form
Simultaneous Quantification RP-HPLC Method Development and Validation for Atorvastatin and Tadalafil in Bulk Form
Background: Tadalafil and Atorvastatin together have been shown to significantly enhance hemodynamics and sexual performance in middle-aged and older patients with hyperlipidemia. ...
Effects of atorvastatin on transient sodium currents in rat normal/simulated ischemia/reperfusion ventricular cell
Effects of atorvastatin on transient sodium currents in rat normal/simulated ischemia/reperfusion ventricular cell
Background
Some clinical trials have shown statins have anti-arrhythmic effects and can improve clinical results. But its mechanism is unclear.
...

